About this trial
This study looks at a new device called Addinex that helps manage pain after cancer surgery. It safely stores and gives out opioid medicine to patients. The goal is to see if patients prefer this device over traditional pill bottles. Participants will answer questions about their experiences and use a mobile app with the device. The results may help future patients manage their pain better after surgery.
The trial ID is NCT05585788. It is not in a specific phase but is focused on how well the device works and its safety. This study is regulated by the FDA as a device and aims to include about 140 participants.
Who can join
This trial is open to adults aged 18 to 99. It includes both men and women who are having major cancer surgery and will need pain medicine afterward. Participants must speak English or Spanish and have access to a smartphone or similar device. Some patients may not qualify, like those taking opioids daily before surgery or those who cannot use the device.
Conditions
Opioid Use, Breast Cancer
Age group
Adult, Older adult
The study team makes the final call on eligibility.
What happens in the study
Everyone in the study will use the Addinex system. This device gives out opioid medicine on a schedule set by their doctor. It also helps track how the patient uses it and allows for returning any unused opioids. Participants will not be randomly assigned to different groups.
Where
This trial is running at 1 location in the United States. It is currently recruiting.
Columbia University Medical Center
New York, New York